V2 sact_regimen
781,388 rows · 12 columns
| ENCORE_PATIENT_ID | MERGED_REGIMEN_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | BENCHMARK_GROUP | LINK_NUMBER |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 20167684 | 20158000 | 1.67 | 60 | Neo-adjuvant (N) | 2020-05-05 | 2021-01-28 | Hepatoblastoma SR Cisplatin | 02 | null | CARBOPLATIN + DOXORUBICIN + MITOMYCIN | 100773168 |
| 20168615 | 20158001 | null | null | null | null | 2017-07-06 | IRINOTECAN + MDG + PANITUMUMAB | N | N | BEVACIZUMAB + FLUOROURACIL + OXALIPLATIN | 101279647 |
| 20169092 | 20158003 | 1.71 | 98.45 | Adjuvant (A) | 2018-03-12 | 2018-03-19 | VINORELBINE | N | N | CETUXIMAB + FLUOROURACIL | 100274021 |
| 20169180 | 20158005 | 1.8 | 86 | Palliative (P) | 2018-01-19 | 2018-01-23 | Vinorelbine (oral) | 02 | N | CAPECITABINE + STREPTOZOCIN | 100813839 |
| 20170223 | 20158007 | 0 | 81.9 | Palliative (P) | 2021-03-08 | 2021-03-08 | CAPECITABINE + IRINOTECAN + Panitumumab | 02 | N | GEMCITABINE + OXALIPLATIN | 100854169 |
| 20170818 | 20158009 | 1.75 | null | null | 2017-11-06 | 2020-01-12 | null | 02 | N | CYTARABINE | 100531977 |
| 20171067 | 20158010 | 1.87 | 79.3 | Palliative (P) | 2020-09-27 | 2020-10-11 | ISATUXIMAB + POMALIDOMIDE | 02 | N | CISPLATIN + FLUOROURACIL + TRASTUZUMAB | 101456253 |
| 20171250 | 20158011 | null | null | null | 2016-06-24 | 2017-05-05 | Eribulin | 02 | null | BEVACIZUMAB + CARBOPLATIN + PACLITAXEL | 101195363 |
| 20171355 | 20158012 | 1.49 | 76.7 | 03 | 2018-03-25 | 2018-04-06 | CYCLOPHOSPHAMIDE + MTX | 02 | N | IBRUTINIB | 100547999 |
| 20171611 | 20158013 | 1.75 | 100.8 | null | 2017-05-15 | 2017-05-15 | AML 19 TRIAL | 02 | N | CAPECITABINE + STREPTOZOCIN | 100691231 |
| 20171685 | 20158014 | 1.88 | 73.6 | null | 2022-03-07 | 2022-03-12 | TEMOZOLOMIDE | 02 | null | PEMIGATINIB | 100753451 |
| 20172335 | 20158017 | 1.7 | 68 | null | 2020-06-02 | 2020-06-02 | CISPLATIN + FLUOROURACIL + RT | 02 | N | CISPLATIN + FLUOROURACIL + RT | 101193831 |
| 20172650 | 20158018 | 1.69 | 73.1 | Palliative (P) | 2017-09-24 | 2017-11-18 | IBRUTINIB | 02 | null | CHOP R | 100315898 |
| 20173337 | 20158020 | 1.65 | 86.1 | null | 2018-02-04 | 2018-04-08 | Cyclophosphamide High Dose | 02 | null | CARBOPLATIN + RALTITREXED | 100025739 |
| 20174214 | 20158021 | 1.77 | 53.7 | Palliative (P) | 2018-03-25 | 2018-03-25 | WT Guidelines Cyclophos/Doxorubicin | 02 | Y | IRINOTECAN + FLUOROURACIL | 101334088 |
| 20174446 | 20158022 | 1.84 | 57.6 | null | 2015-08-20 | 2015-09-07 | PERTUZUMAB + TRASTUZUMAB | 02 | null | BORTEZOMIB | 100430350 |
| 20175225 | 20158023 | 1.81 | 62.3 | Palliative (P) | 2017-11-23 | 2019-02-18 | FLUOROURACIL + Panitumumab | 02 | N | AML19 TRIAL | 101497599 |
| 20175290 | 20158024 | 1.71 | 0 | 03 | 2019-01-31 | 2019-02-01 | Rituximab | 02 | N | CAPECITABINE + CARBOPLATIN + RT | 101297314 |
| 20175696 | 20158025 | 1.6 | 74.9 | Palliative (P) | null | 2018-06-28 | CHOP R | null | N | FLUDARABINE | 100154282 |
| 20175860 | 20158027 | 1.9 | null | null | 2018-07-24 | 2018-09-04 | Cyclophosphamide Weekly PO | null | null | MITOXANTRONE | 101851228 |
| 20176343 | 20158028 | 1.86 | 87 | Palliative (P) | 2022-05-07 | 2022-05-14 | Cetuximab + FLUOROURACIL | 02 | Y | BRIGATINIB | 100305895 |
| 20176672 | 20158029 | 1.77 | 51.3 | Curative (C) | 2017-09-19 | 2018-03-14 | CHOP R | 02 | N | FCARBOST | 100764749 |
| 20176772 | 20158030 | 1.81 | 85.8 | Curative (C) | 2015-11-01 | 2017-07-29 | null | 02 | N | CABAZITAXEL | 101801059 |
| 20177203 | 20158031 | 1.69 | 66.2 | Palliative (P) | null | 2020-07-19 | null | null | N | ERIBULIN | 100570393 |
| 20177353 | 20158032 | null | null | Palliative (P) | 2021-06-30 | 2021-07-30 | CYCLOPHOSPHAMIDE + POMALIDOMIDE | 02 | N | GEMCITABINE + PACLITAXEL | 100997655 |
| 20177553 | 20158034 | null | null | Palliative (P) | 2020-02-27 | 2020-03-13 | Bortezomib + Panobinostat | 02 | N | NAB-PACLITAXEL | 100565509 |
| 20178586 | 20158036 | 1.32 | 94.6 | Palliative (P) | 2022-05-09 | 2022-05-17 | CISPLATIN + FLUOROURACIL + RT | 02 | Y | PACLITAXEL + RAMUCIRUMAB | 101870276 |
| 20178873 | 20158037 | 1.71 | 66.8 | Palliative (P) | 2016-09-29 | 2016-10-06 | Olaparib | 02 | N | TEMOZOLOMIDE | 100843706 |
| 20180081 | 20158038 | 1.82 | 51.3 | null | 2020-11-16 | 2020-11-22 | null | 02 | N | RITUXIMAB | 100358723 |
| 20180262 | 20158039 | 1.83 | 53.9 | null | 2018-08-28 | 2019-01-21 | CT7001 | 02 | null | HEPATOBLASTOMA RELAPSE VI | 101469714 |
| 20180381 | 20158040 | 1.85 | 67.1 | Palliative (P) | 2020-08-31 | 2020-08-31 | Capecitabine+Cisplatin+Streptozocin | 02 | N | OXALIPLATIN + MDG + PANITUMUMAB | 100722021 |
| 20180904 | 20158041 | 1.77 | 56 | Palliative (P) | 2018-09-11 | 2018-09-28 | Venetoclax | 02 | null | INTERAACT TRIAL | 100544999 |
| 20180926 | 20158042 | 1.65 | 70 | Curative (C) | 2019-09-08 | 2019-10-18 | Epirubicin | N | N | BACILLUS CALMETTE-GUERIN | 100350853 |
| 20182177 | 20158045 | 1.56 | 53.5 | Palliative (P) | 2018-09-25 | 2019-01-02 | CAPE + OXALIPLATIN + TRASTUZUMAB | 02 | N | ABEMACICLIB + FULVESTRANT | 100068210 |
| 20182493 | 20158047 | 1.6 | 90.7 | Palliative (P) | 2017-03-16 | 2017-03-16 | DARATUMUMAB | null | null | CISPLATIN + GEMCITABINE + RITUXIMAB | 100817564 |
| 20182899 | 20158049 | 1.58 | 53 | Palliative (P) | 2019-10-14 | 2019-11-06 | BCG Intravesical | 02 | N | CYCLOPHOSPHAMIDE + DOXORUBICIN + VINCRISTINE | 101178269 |
| 20183306 | 20158050 | 1.77 | 55.05 | Palliative (P) | 2019-10-08 | 2021-03-15 | THALIDOMIDE | 02 | null | IRINOTECAN + MDG + PANITUMUMAB | 100379481 |
| 20183463 | 20158051 | 1.58 | 108 | null | 2016-11-05 | 2016-11-16 | Carboplatin + Vinorelbine Oral | 02 | null | CAPE + OXALIPLATIN + TRASTUZUMAB | 101746146 |
| 20183881 | 20158052 | 1.77 | 61.7 | Curative (C) | 2021-06-01 | 2021-06-08 | Cisplatin + Docetaxel | 02 | N | IXAZOMIB + LENALIDOMIDE | 101069314 |
| 20183907 | 20158053 | 1.6 | 74.4 | null | 2019-08-20 | 2020-01-15 | Carboplatin + Liposomal Doxorubicin | 02 | null | ECF | 101672692 |
| 20184308 | 20158054 | 1.58 | 89 | Adjuvant (A) | 2021-11-07 | 2021-12-05 | Bendamustine + Obinutuzumab | 02 | N | VENETOCLAX | 100669532 |
| 20184496 | 20158055 | 1.86 | null | Disease modification (D) | 2018-03-16 | 2018-03-17 | Capecitabine+Cisplatin+Streptozocin | N | null | ACTICCA-1 TRIAL | 100023712 |
| 20184560 | 20158056 | 1.57 | 68.2 | null | 2019-07-01 | 2019-07-01 | Gemcitabine + Oxaliplatin | 02 | null | TOPOTECAN | 101540921 |
| 20184820 | 20158057 | 0 | 42 | Palliative (P) | 2016-05-11 | 2016-05-22 | Cisplatin + Docetaxel | 02 | N | CARMUSTINE + CYTARABINE + ETOPOSIDE + MELPHALAN | 100129984 |
| 20184976 | 20158058 | 1.75 | 67.8 | Disease modification (D) | 2018-05-11 | 2018-05-11 | FEC 100 | N | N | COSMIC TRIAL | 100602943 |
| 20185051 | 20158059 | 1.83 | 58.9 | Palliative (P) | 2020-01-15 | 2020-02-03 | TRASTUZUMAB EMTANSINE | 02 | N | TRABECTEDIN | 101307877 |
| 20185965 | 20158060 | 0 | 55 | Palliative (P) | 2021-03-17 | 2021-04-26 | null | 02 | N | TISAGENLECLEUCEL (KYMRIAH) + FLUDARABINE + CYCLOPHOSPHAMIDE | 101692704 |
| 20186389 | 20158061 | 1.79 | 63.4 | null | 2019-11-25 | 2019-11-30 | THALIDOMIDE | 02 | null | CYCLOPHOSPHAMIDE + FLUDARABINE | 101404371 |
| 20187029 | 20158062 | 1.65 | 103 | Palliative (P) | 2018-10-07 | 2018-11-04 | Chlorambucil | 02 | N | STREPTOZOCIN + MDG | 101274546 |
| 20187184 | 20158063 | 1.65 | 74 | Neo-adjuvant (N) | 2020-02-27 | 2020-03-12 | IPILIMUMAB + NIVOLUMAB | 02 | null | EPIRUBICIN | 101518294 |